Cargando…
Onabotulinum toxin A vs. incobotulinum toxin A for the treatment of chronic migraine: a retrospective review
BACKGROUND: Onabotulinum toxin A (OnA) is a well-tolerated and effective treatment for chronic migraine (CM). However, based on research indications that incobotulinum toxin A (InA) would be equally effective, a Veterans’ Health Administration Medical Center mandated a 2-year trial of InA as more co...
| Autores principales: | , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
American Journal Experts
2023
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10055501/ https://www.ncbi.nlm.nih.gov/pubmed/36993755 http://dx.doi.org/10.21203/rs.3.rs-2624326/v1 |